Neurocrine Biosciences Inc (NBIX)
139.36
-1.19
(-0.85%)
USD |
NASDAQ |
May 22, 16:00
139.36
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Cash from Investing (Quarterly): -55.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -55.00M |
| December 31, 2023 | -201.80M |
| September 30, 2023 | -97.30M |
| June 30, 2023 | -125.90M |
| March 31, 2023 | -42.10M |
| December 31, 2022 | -115.60M |
| September 30, 2022 | -61.30M |
| June 30, 2022 | 31.40M |
| March 31, 2022 | -31.60M |
| December 31, 2021 | 23.70M |
| September 30, 2021 | -126.20M |
| June 30, 2021 | -90.80M |
| March 31, 2021 | 63.10M |
| December 31, 2020 | -147.70M |
| September 30, 2020 | 25.20M |
| June 30, 2020 | 93.40M |
| March 31, 2020 | 33.20M |
| December 31, 2019 | -166.20M |
| September 30, 2019 | -85.60M |
| June 30, 2019 | -0.30M |
| March 31, 2019 | 41.00M |
| December 31, 2018 | -106.24M |
| September 30, 2018 | -45.10M |
| June 30, 2018 | -34.51M |
| March 31, 2018 | -57.05M |
| Date | Value |
|---|---|
| December 31, 2017 | -59.39M |
| September 30, 2017 | -35.39M |
| June 30, 2017 | -213.31M |
| March 31, 2017 | 56.85M |
| December 31, 2016 | 15.16M |
| September 30, 2016 | 43.20M |
| June 30, 2016 | -15.66M |
| March 31, 2016 | 70.26M |
| December 31, 2015 | 22.05M |
| September 30, 2015 | -47.86M |
| June 30, 2015 | -53.91M |
| March 31, 2015 | -116.09M |
| December 31, 2014 | 15.54M |
| September 30, 2014 | 3.216M |
| June 30, 2014 | -58.40M |
| March 31, 2014 | -65.73M |
| December 31, 2013 | 20.73M |
| September 30, 2013 | -1.305M |
| June 30, 2013 | 20.99M |
| March 31, 2013 | -35.08M |
| December 31, 2012 | 27.89M |
| September 30, 2012 | 10.66M |
| June 30, 2012 | -28.09M |
| March 31, 2012 | -45.22M |
| December 31, 2011 | -0.451M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-201.80M
Minimum
Dec 2023
93.40M
Maximum
Jun 2020
-53.87M
Average
-58.15M
Median
Cash from Investing (Quarterly) Benchmarks
| Globus Medical Inc | -46.58M |
| Inspire Medical Systems Inc | -19.54M |
| AIM ImmunoTech Inc | -0.158M |
| Protalix BioTherapeutics Inc | -0.606M |
| Armata Pharmaceuticals Inc | -0.25M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 130.30M |
| Cash from Financing (Quarterly) | 69.90M |
| Free Cash Flow | 614.40M |
| Free Cash Flow Per Share (Quarterly) | 1.150 |
| Free Cash Flow to Equity (Quarterly) | 30.20M |
| Free Cash Flow to Firm (Quarterly) | 120.48M |
| Free Cash Flow Yield | 4.33% |